Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy February 9, 2026
ALPS Global Holding Berhad Reaches New Milestone in IPO Journey: Form F-4 Prospectus Now Live December 26, 2024
